In recent years, there have been significant advances in our understanding of the mucosal immune system. In addition to unravelling some of the complexities of this system, including the discovery of completely new cells types, further insights into the three-way interactions between mucosal immune cells, the intestinal epithelium and the microbial communities colonizing the GI tract promise to redefine our understanding of how intestinal homeostasis is maintained, but also how dysregulation of these highly integrated interactions conspires to cause disease. In this review, we will discuss major recent advances in the role of key immune players in the gut, including innate lymphoid cells (ILCs), mucosa-associated invariant T cells (MAIT cells) and cells of the mononuclear phagocyte system (MPS), including how these cells interact with the intestinal epithelial and their crosstalk with components of the intestinal microbiota, and how these interactions shape host health.
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| INTRODUCTION
The last 10 years have seen a transformation in the understanding of the mucosal immune system in health and disease. Technological advances in high-throughput sequencing and informatics have allowed the characterization of the microbial communities in the gut and other sites. This has been achieved in a number of ways: firstly, by pyrosequencing 16SrRNA using region-specific primers or secondly using random DNA sequencing to assemble the aggregate of genes in the microbiome-the metagenome. Thirdly, there has been a large increase in the number of gnotobiotic facilities, where mice can be maintained germ-free or with defined microbial communities. This has allowed not only the characterization of how the immune system shapes the microbiota but also how the microbiota shapes the immune system. It is widely and somewhat incorrectly stated that bacterial In this review, we would like to give an update on some aspects of mucosal immunology which have developed in the last 10 years.
| INNATE LYMPHOID CELLS (ILCS)

| Innate lymphoid cells-new players at the barrier surfaces
Innate lymphoid cells are a family of mucosal-dwelling innate lymphocytes that are enriched at barrier surfaces. They lack recombined antigen-specific receptors, such as those found on T cells and B cells. 
| Innate lymphoid cell differentiation
A detailed review of ILC development and differentiation has been recently published. 12 In short, these innate lymphocytes develop from haematopoietic stem cells (HSCs) via increasingly well-defined intermediaries, under the direction of specific transcription factors, which serve as molecular switches that control cell fate decisions. In 
| Crosstalk between ILCs and T cells regulates mucosal homeostasis
Dialogue between ILCs and T cells plays an important role in the initiation and evolution of mucosal immune responses, which simul- ILC2 can also prime antigen-specific naïve T-cell responses, including induction of proliferation and cytokine production. 25 Although ILC2
are less effective at driving T-cell activation than professional APCs, such as DC, they have comparable efficiency to B cells. 25 In addition to their role as direct primers of antigen-specific CD4 + T cells, ILC2 also indirectly impact memory CD4 + T-cell recruitment to the tissues through crosstalk with DCs. In models of allergen-driven memory Th2 cell-dependent eosinophilic lung inflammation, ILC2 accumulate in the tissue at early time points prior to the arrival of memory Th2 T cells. 26 Selective depletion of ILC2 in this context results in impaired recruitment of memory Th2 cells resulting from loss of early IL-13 by tissue ILC2 which is responsible for triggering upregulation of the chemokine CCL17 by IRF4 + CD11b + CD103 -mononuclear phagocytes, which attracts CCR4 expressing Th2 memory T cells. 26 The cognate interaction between T cells and ILCs reciprocally activates ILCs, through T-cell production of the key ILC2 growth factor, IL-2.
| Innate lymphoid cells regulate barrier protection
ILCs are important early responders to pathogen invasion, and experi- 
| ILCs and inflammatory bowel disease
In contrast to their role in host immunity and maintenance of intesti- 
| The role of ILCs in antihelminth immunity
| THE INTESTINAL MICROBIOTA
Culture-independent technologies, including next generation sequencing, have revolutionized our understanding of the microbial colonies populating the gastrointestinal tract and the functional contribution of these communities to host health. The metagenome (genes carried by our colonizing microbes) profoundly impacts wide-ranging aspects of the host phenotype, including metabolic, endocrine, neurological and immunological factors. Remarkably, cumulatively as a species, humans possess an additional 10 million genes contributed by intestinal bacteria. 46 Intestinal microbial communities are diverse and although there are hundreds of different bacterial species colonizing the human gut, the community structure differs across human populations according to age, diet, geographic distribution and host genetics. 46 Crucially, significant perturbation of the community structure of intestinal bacteria, or dysbiosis, is linked to important alterations in host immunity and susceptibility to immune-mediated diseases both within and beyond the gut.
| The intestinal microbiota profoundly influence mucosal and systemic T-cell responses
In recent years, important advances have been made in our understanding about how specific components of the intestinal microbiota directly shape specific aspects of host immune responses ( Figure 2 ).
Unless mice are colonized with an unculturable Clostridia-like bacterium called segmented filamentous bacteria (SFB), they are unable to mount effective Th17 responses. 47 SFB colonize the small intestine and are found in highest numbers in the terminal ileum, a key inductive site for T cells, and to a lesser extent the proximal small intestine and colon. 47 As well as impacting on local intestinal Th17 responses, intestinal colonization with SFB is also required to generate Th17 responses at sites remote from the gut, which in turn impacts on the susceptibility of the host to systemic inflammation. 
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Segmented filamentous bacteria do not colonize the human intestine; however, it is possible that bacteria with similar characteristics, such as the capacity to tightly adhere to the intestinal epithelium, may be permissive for Th17 responses in man.
| The intestinal microbiota control regulatory T-cell (Treg) development
Selective bacteria can also promote the differentiation of Tregs.
Inoculation of a consortium of seventeen Clostridia strains isolated from healthy human colon into germ-free mice triggers mucosal production of TGF-β, which results in expansion of IL-10-producing 
| INTESTINAL MACROPHAGES
| Origin of tissue macrophages
For many years, it was considered that tissue macrophages such as Kupffer cells in the liver, microglia in the brain, and Langerhans cells in the skin were tissue-resident cells constantly being replaced by monocytes from the blood, themselves derived from hematopoietic stem cells in the bone marrow. However, in 2010 using bone-marrow chimeras, parabiotic mice, fate mapping and macrophage colonystimulating factor 1 (CSF-1) and CSF-R null mice it was discovered that microglia in the brain, but not lung macrophages, were not bonemarrow derived, but were derived from the foetal yolk sac at 9.5 days post-conception. 66 This was confirmed -in 2012 when it was shown that Langerhans cells in the skin and Kupffer cells in the liver were also derived from the yolk sac and not hematopoietic stem cells in the marrow. In tissues, these yolk sac-derived macrophages are selfrenewing. 67 However, when many of the same methodologies used by Ginhoux et al. were used to study intestinal macrophages, it was discovered that although macrophages from the yolk sac entered the foetal gut, they did not persist into adulthood. 68 In fact after weaning, virtually all macrophages in the mouse gut are derived from hematopoietic stem cells. Their presence also depends on the microbiota. 
| Novel pathways for antigen sampling by macrophages in the gut
It had also traditionally been considered that the way in which the immune system sampled luminal antigens was via the phagocytic 
IL-10
PsA OMV SCFA
activity of M cells on the domes of Peyer's patches and isolated lymphoid follicles in the small intestine and colon. However, using CX3CR1-GFP reporter mice (the fractalkine receptor), it was shown in the mouse ileum that CX3CR1-GFP+ dendritic cells send processes between epithelial cells to sample bacteria directly from the gut lumen and then withdraw the dendrites back to the cell body in the lamina propria. 69 Further studies have shown that the cells sending dendrites through the epithelium are not dendritic cells, but macrophages, because they are highly phagocytic and express F4/80, CD64 and CD11b. 70 Other studies showed that a subset of dendritic cells expressing lysozyme in the subepithelial dome of Peyer's patches sent dendrites through pores in M cells to sample gut antigens and then retract back into the tissue. 71 It is clear therefore that
there is an active dialogue between the microbiota, dendritic cells and macrophages across the gut epithelium. It is tempting to speculate that this crosstalk is important in maintaining homeostasis in the healthy gut which is densely infiltrated with immune cells but not inflamed.
| Function of intestinal macrophages
In contrast to an extensive literature on fate mapping and phenotype of intestinal macrophages, functional studies on gut macrophages are still relatively few. It is important also to appreciate that there may be major differences between the small bowel and the colon and between species. In the small bowel, the macrophages are in the cores of the villi but in the colon, they form a layer immediately below the epithelium. A final issue is that it is rather difficult to isolate live macrophages from the gut for functional studies because of their low numbers.
Nonetheless, small intestinal macrophages from healthy human gut are highly unusual cells. They mostly lack innate receptors such as CD14 and therefore do not respond to lipopolysaccharide. In fact they are profoundly anergic to stimuli that evoke rapid cytokine production in monocytes. In contrast, they are highly phagocytic and bacteriocidal. 72 In mouse colon, there is a similar population of cells which may also make IL-10, 73 but there is no evidence that macrophages in healthy human gut make IL-10. It would appear therefore that in normal gut the function of most lamina propria macrophages is to phagocytose bacteria (both commensals and pathogens) crossing the epithelium, without evoking a strong inflammatory response.
It is thought that transforming growth factor-β production by stromal cells is responsible for rendering intestinal macrophages anergic. activation. 75 One of the features of chronic inflammatory bowel disease in man, especially Crohn's disease is a dramatic increase in macrophages derived from blood monocytes. These cells express CD14 and produce large amounts of pro-inflammatory cytokines such as TNF-α, IL-12 and IL-6.
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A feature of Th2 responses in the peritoneum, pleural cavity and liver is that IL-4 drives local macrophage proliferation. 77 As described above, there is crosstalk between ILC2 and conventional T cells in the gut, but it is not known whether in Th2 responses driven by intestinal parasites, impacts local division of macrophages.
| RETINOIC ACID
One of the most important discoveries in mucosal immunology in recent years has been the discovery that gut-specific homing of T and B cells from gut-associated lymph tissue (GALT) to the lamina propria is driven by dietary vitamin A. 78 In meat products, vitamin A is found in the form of retinyl palmitate which is converted into retinol in the small intestine. After absorption, retinol is converted into alltrans retinoic acid by retinol dehydrogenase and retinaldehyde dehy- Retinoic acid also has other functions in the gut. Recently it has been shown that retinoic acid secreted by macrophages is proinflammatory in the gut as it drives the differentiation of TNF-α secreting macrophages. 79 Retinoic acid secreted by lamina propria DCs and transforming growth factor-β also are highly effective at generating
Tregs. 80 It has also been demonstrated that retinoic acid inhibits Th17 cell development and also drives T cells to become Tregs. 81 The situation is further complicated by the observation that retinoic acid is needed to maintain Th1 stability and inhibits their ability to become Th17 cells. 82 Further studies are needed to unravel the apparently contradictory roles of retinoic acid in the gut.
| MUCOSA-ASSOCIATED INVARIANT T CELLS (MAIT CELLS)
In 2003, a new population of cells was identified in human gut expressing a semi-invariant TcR using TRAV1-2-TRAJ33 and TRBV6
and TRBV20. In mouse gut, TcR usage of MAIT cells is TRAV19, and TRAJ33. 83 At the same time, it was discovered that these unusual MAIT cells are uncommon, the majority either being CD8+ or CD4-, 
| CONCLUSIONS
It is fascinating to consider that ILCs were only identified in 2010, many years after the lymphoid family was thought to be complete.
There has been an explosion of publications since then. The challenge remains however to identify their role in a lymphocyte-replete ani- T A B L E 1 Characteristics of mucosa-associated invariant T cells 
